Nav: Home

UK improves cancer survival, but is still behind other high-income countries

September 11, 2019

Cancer survival in the UK has improved since 1995, although it still lags behind other high-income countries, according to new analysis* by the International Cancer Benchmarking Partnership (ICBP), which is managed by Cancer Research UK.

The study, published in Lancet Oncology, looked at 3.9 million cancer cases between 1995 and 2014, in seven comparable countries (Australia, Canada, Denmark, Ireland, New Zealand, Norway and the UK).

This is the first international study to look at changes in cancer survival alongside incidence and mortality for cancers of the oesophagus, stomach, colon, rectum, pancreas, lung and ovary. Exploring these three key measures allows us to better understand how countries like the UK compare in the prevention, diagnosis and treatment of different cancers.

Encouragingly, one-year and five-year survival has improved across all seven cancer sites in the UK across the 20-year period. Five-year survival for rectal cancer in the UK rose by 14 percentage points** since 1995, from 48% to 62%. The UK also has one of the highest increases in five-year survival - almost 12 percentage points - across all countries for colon cancer. This can potentially be attributed to advances in treatment such as better surgery, among other factors.

Additionally, one-year survival for lung, ovarian and oesophageal cancer all increased by around 15 percentage points in the last 20 years. Though great progress has been made, the UK remains near the bottom of the rankings, and has not yet caught up with the other countries.

Cancer Research UK's clinical adviser, John Butler, who co-authored the study and is a consultant surgeon at the Royal Marsden, said: "There isn't one specific reason why survival in the UK has improved - it's a combination of many different factors. Over the last twenty years we've seen improvements in cancer planning, development of national cancer strategies and the rollout of new diagnostic and treatment services.

"For lung, ovarian, and oesophageal cancer in particular, survival has increased largely because the quality of surgery has radically improved, and more surgery is taking place than before. More people are being looked after by specialist teams, rather than surgeons who aren't experts in that area. But while we're still researching what can be done to close the survival gap between countries, we know continued investment in early diagnosis and cancer care plays a big part. Despite our changes we've made slower progress than others."

Sara Hiom, Cancer Research UK's director of early diagnosis, said: "More people than ever before are surviving cancer thanks to research and targeted improvements in care. But, while we're on the right track, the numbers show we can certainly do better.

"We will not see the necessary improvements in diagnosis and access to treatment unless we have enough of the right staff across our NHS. Cancer Research UK has been calling for staff shortages to be addressed because, quite simply, it will give people a better chance of surviving their cancer. If we are to achieve world class cancer outcomes in the UK, then we need to see comparable investment in the NHS and the systems and innovations that support it. It's never been a more crucial time for the Government to put new money where it matters."
-end-


Cancer Research UK

Related Cancer Articles:

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
More Cancer News and Cancer Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Risk
Why do we revere risk-takers, even when their actions terrify us? Why are some better at taking risks than others? This hour, TED speakers explore the alluring, dangerous, and calculated sides of risk. Guests include professional rock climber Alex Honnold, economist Mariana Mazzucato, psychology researcher Kashfia Rahman, structural engineer and bridge designer Ian Firth, and risk intelligence expert Dylan Evans.
Now Playing: Science for the People

#541 Wayfinding
These days when we want to know where we are or how to get where we want to go, most of us will pull out a smart phone with a built-in GPS and map app. Some of us old timers might still use an old school paper map from time to time. But we didn't always used to lean so heavily on maps and technology, and in some remote places of the world some people still navigate and wayfind their way without the aid of these tools... and in some cases do better without them. This week, host Rachelle Saunders...
Now Playing: Radiolab

Dolly Parton's America: Neon Moss
Today on Radiolab, we're bringing you the fourth episode of Jad's special series, Dolly Parton's America. In this episode, Jad goes back up the mountain to visit Dolly's actual Tennessee mountain home, where she tells stories about her first trips out of the holler. Back on the mountaintop, standing under the rain by the Little Pigeon River, the trip triggers memories of Jad's first visit to his father's childhood home, and opens the gateway to dizzying stories of music and migration. Support Radiolab today at Radiolab.org/donate.